Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 17/04/2012
PIL ViraferonPeg Pen 50, 80, 100, 120 or 150 micrograms powder and solvent for solution for injection in pre-filled pen

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 23/01/2012 and displayed until 17/04/2012
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 26/09/2011 and displayed until 23/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to information about pregnancy or lactation
Updated on 24/08/2011 and displayed until 26/09/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to Marketing Authorisation Holder
Updated on 23/11/2010 and displayed until 24/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 24/05/2010 and displayed until 23/11/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 29/01/2010 and displayed until 24/05/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
Updated on 27/01/2010 and displayed until 29/01/2010
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  peginterferon alfa-2b